Basil Moore

Ask VT AI
View News Summary
  • Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.
  • The European Central Bank is moving forward with plans for a digital euro, with a pilot potentially launching by mid-2027 and first issuance targeted for 2029 if EU lawmakers approve the necessary legal framework.
  • NCAA's decision to allow former G League players to regain Division I eligibility draws criticism from coaches like Tom Izzo and Matt Painter, who warn it could disrupt recruiting and the sport's future.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.
  • The European Central Bank is moving forward with plans for a digital euro, with a pilot potentially launching by mid-2027 and first issuance targeted for 2029 if EU lawmakers approve the necessary legal framework.
  • NCAA's decision to allow former G League players to regain Division I eligibility draws criticism from coaches like Tom Izzo and Matt Painter, who warn it could disrupt recruiting and the sport's future.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Basil Moore